TipRanks
Go Ultimate55% OFF

NKGen Biotech (NKGN) Income Statement

NKGen Biotech Income Statement

Last quarter (Q1 2025), NKGen Biotech's total revenue was $0.00. In Q1, NKGen Biotech's net income was $15.35M. See NKGen Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 77.00K$ 426.00K
$ 0.00$ 0.00$ 59.00K$ 396.00K
$ 26.97M$ 29.75M$ 24.41M$ 22.26M
Depreciation and Amortization$ 1.31M$ 1.20M$ 1.21M$ 1.24M
$ -40.19M$ -81.00M$ -23.23M$ -20.70M
$ -26.97M$ -29.75M$ -24.35M$ -21.86M
$ -17.27M$ -53.20M$ -2.40M$ -1.40M
$ -44.23M$ -82.95M$ -26.75M$ -23.26M
$ -44.29M$ -82.95M$ -26.75M$ -23.27M
Per Share Metrics
Basic EPS$ -1.54$ -5.38$ -1.25$ -1.08
Diluted EPS$ -1.54$ -5.38$ -1.25$ -1.08
Weighted Average Shares Outstanding28.83M15.43M21.45M21.45M
Weighted Average Shares Outstanding (Diluted)28.83M15.43M21.45M21.45M

Currency in USD

NKGen Biotech Earnings and Revenue History

-100M-50M050M-45000 %-30000 %-15000 %0 %EarningsProfit Margin2021202220232024RevenueEarningsProfit Margin